Fast-Acting Insulin Aspart Comparison in Closed Loop Delivery System for Type 1 Diabetes

Fast-Acting Insulin Aspart Comparison in Closed Loop Delivery System for Type 1 Diabetes

Bydiabetesknow

Previously Published on Endocrinologyadvisor.com  – Findings from a 17-week, randomized, open-label, crossover study comparing the efficacy of fast-acting insulin aspart (faster aspart)  with standard insulin aspart (IAsp) delivered by an automated closed-loop system in adults with type 1 diabetes(T1D) showed faster aspart demonstrated greater glucose time in range (TIR) compared with IAsp (82.3% [78.5, 83.7]…

FDA Approves Rapid-acting insulin lispro-aabc Injection for Pump Therapy
|

FDA Approves Rapid-acting insulin lispro-aabc Injection for Pump Therapy

Bydiabetesknow

Previously Published on Healio.com  – The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via continuous subcutaneous infusion with an insulin pump, according to an industry press release. As Healio previously reported, insulin lispro-aabc injection (Lyumjev, Eli Lilly), a novel formulation of insulin lispro developed to speed the absorption of…